News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Merck & Co., Inc.’s Gardasil Prevents HPV Infection, Genital Warts in Men
February 3, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Merck & Co.’s vaccine for warding off a virus that causes cervical cancer in women also reduces infection rates and genital warts in young men, according to a study in the New England Journal of Medicine.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Merck & Co.
MORE ON THIS TOPIC
Podcast
JPM26 Recap, Novo’s Oral Wegovy Soars as Lilly’s Orforglipron Is Delayed, IPOs Return
January 21, 2026
·
1 min read
·
Heather McKenzie
Career Advice
Going With the Flow: Finding Success in Academic and Biotech Research Cultures
January 21, 2026
·
6 min read
·
Manali Shah
Cancer
Moderna, Merck Show Long-Term Survival for mRNA-Keytruda Combo
January 20, 2026
·
2 min read
·
Annalee Armstrong
Lymphoma
AbbVie, Genmab’s Bispecific Misses Key Overall Survival Endpoint in Phase III Lymphoma Study
January 19, 2026
·
2 min read
·
Tristan Manalac